Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective Multicentre Non-Interventional Study to Assess the Patterns of Use of REKOVELLE in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

Trial Profile

Prospective Multicentre Non-Interventional Study to Assess the Patterns of Use of REKOVELLE in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Follitropin delta (Primary)
  • Indications Female infertility
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PROFILE
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 14 Mar 2023 According to a Ferring Pharmaceuticals media release, Professor Christophe Blockeel, from Brussels IVF, the Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel and Vrije Universiteit Brussel is a principal investigator of this study.
    • 14 Mar 2023 According to a Ferring Pharmaceuticals media release, data from this study were first published in the Frontiers of Endocrinology in December 2022.
    • 14 Mar 2023 According to a Ferring Pharmaceuticals media release, data from this study are being presented at the 13th Congress of the Pacific Society for Reproductive Medicine (PSRM) 2023.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top